Sunshine Biopharma Stock Forecast

Sell candidate since May 28, 2026 Loss -38.98%

The Sunshine Biopharma, Inc. stock price fell by -9.24% on the last day (Wednesday, 3rd Jun 2026) from $0.0552 to $0.0501. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 384.63% from a day low at $0.0501 to a day high of $0.243. The price has fallen in 7 of the last 10 days and is down by -60.8% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 thousand shares and in total, 14 thousand shares were bought and sold for approximately $713.73 .

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0443 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.50% during the next 3 months and, with a 90% probability hold a price between $0.0375 and $0.128 at the end of this 3-month period.

SBFMW Signals & Forecast

There are few to no technical positive signals at the moment. The Sunshine Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0841 and $0.0967. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 18, 2026, and so far it has fallen -68.07%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.193 between high and low, or 384.63%. For the last week the stock has had daily average volatility of 227.74%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SBFMW) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Sunshine Biopharma, Inc. to open at $0.114, and during the day (based on 14 day Average True Range), to move between $0 and $0.101, which gives a possible trading interval of +/-$0.102 (+/-101 207.16%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 101 207.16% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

With no support below and resistance from accumulated volume @ $0.0552, some $0.0051 (10.18%) from the current price of $0.0501, our system finds the risk reward not very attractive.

Is Sunshine Biopharma, Inc. stock A Buy?

Sunshine Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.362 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $0.114 ( 128.21%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk